Oncolytics Biotech (ONCY) Misses Q3 EPS by 2c
Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.